Pfizer's Weight-Loss Data Just Upends Investor Bets
Pfizer is stepping into a high-stakes arena long led by Lilly and Novo Nordisk. This article analyzes what pfizer's w...
Benchmarks provide a reference point to gauge portfolio performance and risk. This intro explains how comparing returns against a relevant benchmark clarifies decisions and helps align goals.
22,975 articlesPfizer is stepping into a high-stakes arena long led by Lilly and Novo Nordisk. This article analyzes what pfizer's w...
Beyond Meat trading near its lows has investors weighing a potential turnaround. This article breaks down what to wat...
The AI boom is reshaping how businesses buy computing power. This article breaks down two rising cloud players, why t...
A Phase 3 breakthrough unleashed a dramatic move in Cogent Biosciences. A large fund followed with a sizable stake, s...
New IRS data summarized by the Kiplinger Letter shows the ultra-wealthy paid a 23.61% effective federal tax rate in 2...
A single insider purchase can spark questions about a stock, but it isn’t a sure shot signal. This article digs into ...
Bandwidth Inc. released a mixed Q4 2025 report that sheds light on customer growth, margins, and the path to profitab...
A deep dive into Ted Turner’s debt-fueled rise explains why leveraging growth can backfire. Today’s investors should ...
Dave & Buster's is blending food, drinks, and arcade play into a growing business model. This analysis breaks down th...
Investors rotated into AI infrastructure plays this week, lifting Argan and similar names. This piece breaks down the...
Many retirees have a big asset in their home, but counting home equity fund as retirement income is a risky move. Thi...
A well-known tech software ETF faced heavy selling, but its comeback shows the staying power of enterprise software a...